Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KLS-0611 in Dry Eye Syndromes
NCT00721656Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KLS-0611 in dry eye disease (DED), sponsored by Kissei Pharmaceutical Co., Ltd.. Status: completed.
02
Drugs
KLS-0611
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00721656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00721656.